Ligand Pharmaceuticals Down 9.2% Since SmarTrend's Sell Recommendation

Posted on: Tue, 13 Oct 2009 23:29:00 EDT


Symbols: LGND
Oct 13, 2009 (SmarTrend(R) Spotlight via COMTEX) --
LGND | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called a Downtrend for Ligand Pharmaceuticals (NASDAQ:LGND) on August 31, 2009 at $2.40.

Since then, Ligand Pharmaceuticals has returned 9.2% as of today's recent price of $2.18. Want to profit from these alerts?

Go to www.mysmartrend.com now for a FREE two-week trial.

Write to Chip Brian at cbrian@tradethetrend.com

---------------------------------------------------------------------------------------------

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

For full details on Ligand Pharmaceuticals B (LGND) LGND. Ligand Pharmaceuticals B (LGND) has Short Term PowerRatings at TradingMarkets. Details on Ligand Pharmaceuticals B (LGND) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.